ArticleBMC cancer2024

Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

Cassie Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.